Literature DB >> 2665018

Clinical, clinicopathologic, and hematologic features of Kyasanur Forest disease.

K Pavri1.   

Abstract

In 1957, a fatal disease occurred among monkeys in a forested area of Shimoga District, Karnataka State, India. Concurrently, there was an outbreak of febrile, occasionally fatal illness among people living in the vicinity. The disease was caused by a new tick-borne flavivirus belonging to the Russian spring-summer encephalitis complex of viruses. The early clinical description of the disease included severe cases with hemorrhagic manifestations, including intermittent epistaxis, hematemesis, melena, and frank blood in the stools. Pathologic and hematologic investigations emphasized similarities with Omsk hemorrhagic fever. Two years later there was a shift in clinical emphasis from hemorrhagic to neurologic complications; this could have resulted from the special interests or bias of the principal investigator or the changing patterns of intercurrent infections. Clinical, clinicopathologic, hematologic, and hemostatic features of Kyasanur Forest disease (KFD) are described, particularly in relation to IgE as a cofactor in the immunopathology of KFD and possibly of other hemorrhagic fevers.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2665018     DOI: 10.1093/clinids/11.supplement_4.s854

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  17 in total

Review 1.  Kyasanur forest disease.

Authors:  Michael R Holbrook
Journal:  Antiviral Res       Date:  2012-10-27       Impact factor: 5.970

Review 2.  Ectoparasite defence in humans: relationships to pathogen avoidance and clinical implications.

Authors:  Tom R Kupfer; Daniel M T Fessler
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-07-19       Impact factor: 6.237

3.  Ancient ancestry of KFDV and AHFV revealed by complete genome analyses of viruses isolated from ticks and mammalian hosts.

Authors:  Kimberly A Dodd; Brian H Bird; Marina L Khristova; César G Albariño; Serena A Carroll; James A Comer; Bobbie R Erickson; Pierre E Rollin; Stuart T Nichol
Journal:  PLoS Negl Trop Dis       Date:  2011-10-04

4.  Kyasanur Forest disease virus infection in mice is associated with higher morbidity and mortality than infection with the closely related Alkhurma hemorrhagic fever virus.

Authors:  Kimberly A Dodd; Brian H Bird; Megan E B Jones; Stuart T Nichol; Christina F Spiropoulou
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

Review 5.  Animal models of tick-borne hemorrhagic Fever viruses.

Authors:  Marko Zivcec; David Safronetz; Heinz Feldmann
Journal:  Pathogens       Date:  2013-05-28

6.  Development of single step RT-PCR for detection of Kyasanur forest disease virus from clinical samples.

Authors:  Gouri Chaubal; Prasad Sarkale; Pravin Kore; Pragya Yadav
Journal:  Heliyon       Date:  2018-03-01

7.  Dynamics of human B and T cell adaptive immune responses to Kyasanur Forest disease virus infection.

Authors:  Santhosha Devadiga; Anita K McElroy; Suresha G Prabhu; Govindakarnavar Arunkumar
Journal:  Sci Rep       Date:  2020-09-17       Impact factor: 4.379

8.  Kyasanur Forest disease virus infection activates human vascular endothelial cells and monocyte-derived dendritic cells.

Authors:  Jana Sirmarova; Jiri Salat; Martin Palus; Vaclav Hönig; Helena Langhansova; Michael R Holbrook; Daniel Ruzek
Journal:  Emerg Microbes Infect       Date:  2018-11-07       Impact factor: 7.163

Review 9.  Epidemiology, Pathogenesis, and Control of a Tick-Borne Disease- Kyasanur Forest Disease: Current Status and Future Directions.

Authors:  Syed Z Shah; Basit Jabbar; Nadeem Ahmed; Anum Rehman; Hira Nasir; Sarooj Nadeem; Iqra Jabbar; Zia Ur Rahman; Shafiq Azam
Journal:  Front Cell Infect Microbiol       Date:  2018-05-09       Impact factor: 5.293

Review 10.  Tick-Borne Flaviviruses and the Type I Interferon Response.

Authors:  Richard Lindqvist; Arunkumar Upadhyay; Anna K Överby
Journal:  Viruses       Date:  2018-06-21       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.